Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

Cited by (1,009)

Items 401–500 of 1,009

1. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers
   Antonis C. Antoniou, Karoline B. Kuchenbaecker, Penny Soucy, Jonathan Beesley, Xiaoqing Chen, Lesley McGuffog, Andrew Lee, Daniel Barrowdale, Sue C. Healey, Olga M. Sinilnikova et al. · 2012 · Breast Cancer Research
2. Roles of brca2 (fancd1) in Oocyte Nuclear Architecture, Gametogenesis, Gonad Tumors, and Genome Stability in Zebrafish
   Adriana Rodríguez‐Marí, CATHERINE A. WILSON, Tom A. Titus, Cristian Cañestro, Ruth Bremiller, Yi‐Lin Yan, Indrajit Nanda, Adam B. Johnston, John P. Kanki, Erin M. Gray et al. · 2011 · PLoS Genetics
3. Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis
   Elizabeth Ormondroyd, Louise S. Donnelly, Clare Moynihan, Cornelie Savona, Elizabeth Kathryn Bancroft, D. Gareth Evans, Rosalind A. Eeles, Stuart A. Lavery, Maggie Watson · 2011 · European Journal of Human Genetics
4. Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting <i>BRCA1/2</i> mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium
   Fischer, Christine, Kuchenbäcker, Karoline, Engel, Christoph, Zachariae, Silke, Rhiem, Kerstin, Meindl, Alfons, Rahner, Nils, Dikow, Nicola, Plendl, Hansjörg, Debatin, Irmgard et al. · 2013 · Journal of Medical Genetics
5. Online Tool to Guide Decisions forBRCA1/2Mutation Carriers
   Allison W. Kurian, Diego F. Muñoz, Peter Rust, Elizabeth A. Schackmann, Michael H. Smith, Lauren D. Clarke, Meredith A. Mills, Sylvia K. Plevritis · 2012 · Journal of Clinical Oncology
6. BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer
   Hermela Shimelis, Romy L.S. Mesman, Catharina Von Nicolai, Åsa Ehlén, Lucia Guidugli, Charlotte A. Martin, Fabienne M.G.R. Calléja, Huong Meeks, Emily Hallberg, Jamie Hinton et al. · 2017 · Cancer Research
7. The impact of prophylactic salpingo‐oophorectomy on quality of life and psychological distress in women with a BRCA mutation
   Amy Finch, Kelly A. Metcalfe, Jaclyn Chiang, L. Elit, John R McLaughlin, C. Springate, Mary Jane Esplen, Rochelle Demsky, Joan Murphy, Barry P. Rosen et al. · 2011 · Psycho-Oncology
8. Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians
   Jingxuan Shan, Wijden Mahfoudh, Shoba P. DSouza, Elham Hassen, Noureddine Bouaouina, Sonia Abdelhak, Ahlem Benhadjayed, Hager Memmi, Rebecca Mathew, Idil I. Aigha et al. · 2012 · Breast Cancer Research and Treatment
9. Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers
   Angela R. Bradbury, Comfort N. Ibe, James J. Dignam, Shelly Ann Cummings, Marion S. Verp, M. A. White, Grazia Artioli, L. Dudlicek, Olufunmilayo Ibironke Olopade · 2008 · Genetics in Medicine
10. Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants
    Sarah Jervis, Honglin Song, Andrew Lee, Ed Dicks, Jonathan P. Tyrer, Patricia A. Harrington, Douglas F. Easton, Ian J. Jacobs, Paul D.P. Pharoah, Antonis C. Antoniou · 2013 · Journal of Medical Genetics
11. Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers
    HEBON, Anouk Pijpe, Peggy Manders, Richard M. Brohet, Margriet J Collee, Senno Verhoef, Hans F. A. Vasen, Nicoline Hoogerbrugge, Christie J. van Asperen, Charlotte J. Dommering et al. · 2009 · Breast Cancer Research and Treatment
12. Molecular Mechanisms of PALB2 Function and Its Role in Breast Cancer Management
    Shijie Wu, Jiaojiao Zhou, Kun Zhang, Huihui Chen, Meng Luo, Yuexin Lu, Yuting Sun, Yiding Chen · 2020 · Frontiers in Oncology
13. Homologous recombination proficiency in ovarian and breast cancer patients
    Justin F. Creeden, Nisha S. Nanavaty, Katelyn R. Einloth, Cassidy E. Gillman, Laura Stanbery, Danae Hamouda, Lance D. Dworkin, John J. Nemunaitis · 2021 · BMC Cancer
14. Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes
    Sidrah Shah, Alison Cheung, Mikolaj Kutka, Matin Sheriff, Stergios Boussios · 2022 · International Journal of Environmental Research and Public Health
15. One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations
    Susanne Malander, Mona Ridderheim, Anna Måsbäck, Niklas Loman, Ulf Kristoffersson, Hakan Lars Olsson, Mef Christina Nilbert, Åke Borg · 2003 · European Journal of Cancer
16. Nonequivalent Gene Expression and Copy Number Alterations in High-Grade Serous Ovarian Cancers with BRCA1 and BRCA2 Mutations
    Joshy George, Kathryn Alsop, Dariush Etemadmoghadam, Heather Hondow, Thomas Mikeska, Alexander Dobrovic, Anna DeFazio, Georgia Chenevix‐Trench, Gordon K. Smyth, Douglas A. Levine et al. · 2013 · Clinical Cancer Research
17. Validation of a tool for identifying women at high risk for hereditary breast cancer in population‐based screening
    Kent F. Hoskins, A. Zwaagstra, Michael Ranz · 2006 · Cancer
18. Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: A critical review of the literature
    Ronit Calderon‐Margalit, Ora Paltiel · 2004 · International Journal of Cancer
19. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families
    A. Antoniou, F. Durocher, Paula L. Smith, J. Simard, D. Easton · 2005 · Breast Cancer Research
20. Odds per Adjusted Standard Deviation: Comparing Strengths of Associations for Risk Factors Measured on Different Scales and Across Diseases and Populations: Table 1.
    John Llewelyn Hopper · 2015 · American Journal of Epidemiology
21. Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms
    Miguel de la Hoya, Omar Soukarieh, Irene López‐Perolio, Ana Isabel Vega, Logan C. Walker, Yvette van Ierland, Diana Baralle, Marta Santamariña, Vanessa Lattimore, Juul Wijnen et al. · 2016 · Human Molecular Genetics
22. Understanding inherited genetic risk of adult glioma – a review
    Terri Rice, Daniel Honore Lachance, Annette M. Molinaro, Jeanette E. Eckel‐Passow, Kyle M. Walsh, Jill S. Barnholtz‐Sloan, Quinn T. Ostrom, Stephen Starko Francis, Joseph Leo Wiemels, Robert Brian Jenkins et al. · 2015 · Neuro-Oncology Practice
23. The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance
    Andrew D. Skol, Mark M. Sasaki, Kenan Onel · 2016 · Breast Cancer Research
24. Cancer genetic risk assessment for individuals at risk of familial breast cancer
    Jennifer Hilgart, Bernadette Coles, Rachel Iredale · 2012 · Cochrane Database of Systematic Reviews
25. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
    Huong Meeks, Honglin Song, Kyriaki Michailidou, Manjeet K. Bolla, Joe Dennis, Qin Wang, Daniel Barrowdale, Debra Frost, EMBRACE, Lesley McGuffog et al. · 2015 · JNCI Journal of the National Cancer Institute
26. The germline mutational landscape of BRCA1 and BRCA2 in Brazil
    Edenir Inêz Palmero, Dirce Maria Carraro, Bárbara Alemar, Miguel Angelo Martins Moreira, Ândrea Ribeiro‐dos‐Santos, Kiyoko Abe‐Sandes, Henrique C.R. Galvão, Rui Manuel Reis, Cristiano de Pádua Souza, Natália Campacci et al. · 2018 · Scientific Reports
27. The Role of NQO1 in Ovarian Cancer
    Giovanni Tossetta, Sonia Fantone, Gaia Goteri, Stefano Raffaele Giannubilo, Andrea Ciavattini, Daniela Marzioni · 2023 · International Journal of Molecular Sciences
28. Risk perceptions, worry, and attitudes about genetic testing for breast cancer susceptibility
    Linda D. Cameron, Jeanne Reeve · 2006 · Psychology and Health
29. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations
    Kelly‐Anne Phillips, Ian M Collins, Roger Laughlin Milne, Sue Anne McLachlan, Michael Leonard Friedlander, Martha Hickey, Catharyn J. Stern, John Llewelyn Hopper, Richard Fisher, Gordon Kannemeyer et al. · 2016 · Human Reproduction
30. Magnetic Resonance Imaging in Screening of Breast Cancer
    Yiming Gao, Beatriu Reig, Laura C. Heacock, Debbie Lee Bennett, Samantha Lynn Heller, Linda P. Moy · 2020 · Radiologic Clinics of North America
31. Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population
    Sharon Simchoni, Eitan Friedman, Bella Kaufman, Ruth Gershoni‐Baruch, Avi Orr‐Urtreger, Inbal Kedar‐Barnes, Ronit Shiri‐Sverdlov, Efrat Dagan, Sigal Tsabari, Mordechai Shohat et al. · 2006 · Proceedings of the National Academy of Sciences
32. Differences in Natural History between Breast Cancers in BRCA1 and BRCA2 Mutation Carriers and Effects of MRI Screening-MRISC, MARIBS, and Canadian Studies Combined
    Eveline A.M. Heijnsdijk, Ellen Warner, Fiona J. Gilbert, Madeleine M. A. Tilanus‐Linthorst, D. Gareth Evans, Petrina A. Causer, Rosalind A. Eeles, Reinie Kaas, Gerrit Draisma, Elizabeth A. Ramsay et al. · 2012 · Cancer Epidemiology Biomarkers & Prevention
33. Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study
    Annegien Broeks, Linde M. Braaf, Angelina Huseinovic, Anke Nooijen, Jos H. M. Urbanus, Frans B.L. Hogervorst, Marjanka K. Schmidt, Jan G.M. Klijn, Nicola S. Russell, Flora E. van Leeuwen et al. · 2007 · Breast Cancer Research
34. Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers
    Mae Zakhour, Yael Danovitch, Jenny Lester, B.J. Rimel, Christine Walsh, Andrew John Li, Beth Y. Karlan, Ilana A. Cass · 2016 · Gynecologic Oncology
35. Homologous Recombination Deficiency in Breast Cancer: A Clinical Review
    Wendie D. den Brok, Kasmintan A. Schrader, Sophie B. Sun, Anna V. Tinker, Eric Y. Stutheit-Zhao, Samuel A. J. R. Aparicio, Karen A. Gelmon · 2017 · JCO Precision Oncology
36. Breast cancers, mammary stem cells, and cancer stem cells, characteristics, and hypotheses
    Sébastien Taurin, Haifa Alkhalifa · 2020 · Neoplasia
37. Cancer treatment according to BRCA1 and BRCA2 mutations
    Kara N. Maxwell, Susan M. Domchek · 2012 · Nature Reviews Clinical Oncology
38. Genetic Variation in the One-Carbon Transfer Pathway and Ovarian Cancer Risk
    Linda E. Kelemen, Thomas A. Sellers, Joellen M. Schildkraut, Julie M. Cunningham, Robert Alan Vierkant, V. Shane Pankratz, Zachary S. Fredericksen, Madhura K. Gadre, David N. Rider, Mark Liebow et al. · 2008 · Cancer Research
39. Age at Menarche and Menopause and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study
    Jenny C. Chang-Claude, Nadine Andrieu, Matti A. Rookus, Richard M. Brohet, Antonis C. Antoniou, Susan Peock, Rosemarie Davidson, Louise Izatt, Trevor R. P. Cole, Catherine Noguès et al. · 2007 · Cancer Epidemiology Biomarkers & Prevention
40. Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil
    Magda Conceição Barbosa Gomes, Maurício Magalhães Costa, Radovan Borojević, Álvaro N.A. Monteiro, Roberto José da Silva Vieira, Sérgio Koifman, Rosalina Jorge Koifman, Song Li, Robert Royer, Shiyu Zhang et al. · 2006 · Breast Cancer Research and Treatment
41. Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations
    Richard M. Brohet, Maria E. Velthuizen, Frans B.L. Hogervorst, Hanne E.J. Meijers-Heijboer, Caroline Seynaeve, Margriet J Collee, Senno Verhoef, Margreet G.E.M. Ausems, Nicoline Hoogerbrugge, Christie J. van Asperen et al. · 2013 · Journal of Medical Genetics
42. Reproductive Decision‐Making in Women with BRCA1/2 Mutations
    Jessica L. Chan, Lauren N. C. Johnson, Mary Dupuis Sammel, Laura DiGiovanni, Chan Voong, Susan M. Domchek, Clarisa R. Gracia · 2016 · Journal of Genetic Counseling
43. Tracking progesterone receptor-mediated actions in breast cancer
    Todd Philip Knutson, Carol Ann Lange · 2013 · Pharmacology & Therapeutics
44. BayesMendel: an R Environment for Mendelian Risk Prediction
    Sining Chen, Wenyi Wang, Karl W. Broman, Hormuzd A. Katki, Giovanni Parmigiani · 2004 · Statistical Applications in Genetics and Molecular Biology
45. The detection, treatment, and biology of epithelial ovarian cancer
    Jennifer A. A. Gubbels, Nick Claussen, Arvinder Kapur, Joseph P. Connor, Manish S. Patankar · 2010 · Journal of Ovarian Research
46. The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective
    Julie Dutil, Volha A. Golubeva, Alba L. Pacheco‐Torres, Hector J. Diaz-Zabala, Jaime L. Matta, Álvaro N.A. Monteiro · 2015 · Breast Cancer Research and Treatment
47. BRCA mutations and survival in breast cancer: an updated systematic review and meta-analysis
    Yaning Zhu, Jian Wu, Chengwan Zhang, Suan Sun, Jian Zhang, Wenjie Liu, Jian Huang, Zhihong Zhang · 2016 · Oncotarget
48. Ataxia–Telangiectasia Gene (ATM) Mutation Heterozygosity in Breast Cancer: A Narrative Review
    Katarzyna Joanna Jerzak, Talia Mancuso, Andrea F. Eisen · 2018 · Current Oncology
49. Spectrum and characterisation of BRCA1 and BRCA2deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer
    Eva Macháčková, Lenka Foretová, Mirka Lukesova, Petra Vašíčková, Marie Navrátilová, Ilse Coene, Hana Pavlu, Veronika Kosinová, Jitka Kuklova, Kathleen Claes · 2008 · BMC Cancer
50. Risk reducing mastectomy: outcomes in 10 European centres
    D. Gareth Evans, Andrew D. Baildam, Elaine D C Anderson, A. Brain, Andrew Shenton, Hans F. A. Vasen, Diana Eccles, Anneke Lucassen, Gabriella Pichert, H. Hamed et al. · 2008 · Journal of Medical Genetics
51. Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population
    Wijden Mahfoudh, Noureddine Bouaouina, Slim Ben Ahmed, Sallouha Gabbouj, Jingxuan Shan, Rebecca Mathew, Nancy A. Uhrhammer, Yves‐Jean Bignon, Wafa Troudi, Amel Ben Ammar Elgaaïed et al. · 2011 · Molecular Biology Reports
52. BRCA1 in hormonal carcinogenesis: basic and clinical research
    Eliot M. Rosen, Saijun Fan, Claudine J. Isaacs · 2005 · Endocrine Related Cancer
53. Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program
    Anna Maria Chiarelli, Kristina M. Blackmore, Derek Muradali, Susan J. Done, Vicky Majpruz, Ashini Weerasinghe, Lucia Mirea, Andrea F. Eisen, Linda Rabeneck, Ellen Warner · 2019 · JNCI Journal of the National Cancer Institute
54. A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer
    Carolyn Y. Fang, Carol Cherry, Karthik Devarajan, Tianyu Li, John Malick, Mary B. Daly · 2009 · Gynecologic Oncology
55. BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment
    Ubaldo Martinez‐Outschoorn, Renee M. Balliet, Zhao Lin, Diana Whitaker‐Menezes, Ruth Birbe, Alessandro Bombonati, Stephanos Pavlides, Rebecca Lamb, Sharon Sneddon, Anthony Howell et al. · 2012 · Cell Cycle
56. Adjusting the estimated proportion of breast cancer cases associated with BRCA1 and BRCA2 mutations: Public health implications
    Monica R. McClain, Glenn E. Palomaki, Katherine L. Nathanson, James E. Haddow · 2005 · Genetics in Medicine
57. Modulation of aromatase expression by BRCA1: a possible link to tissue-specific tumor suppression
    Yanfen Hu, Sagar Ghosh, Asma Amleh, Wei Yue, Yunzhe Lu, Adam J. Katz, Rong Li · 2005 · Oncogene
58. Staging and Weighting Evidence in Biomedicine
    Vololona Rabeharisoa, Pascale Bourret · 2009 · Social Studies of Science
59. Breast Cancer Screening
    Mackenzie S Fuller, Christoph I. Lee, Joann G. Elmore · 2015 · Medical Clinics of North America
60. The Validation and Clinical Implementation of BRCAplus: A Comprehensive High-Risk Breast Cancer Diagnostic Assay
    Hansook Kim Chong, Tao Wang, Hsiao‐Mei Lu, Sara Seidler, Hong Yan Lu, Steven B. Keiles, Elizabeth Chao, Aaron J. Stuenkel, Xiang Li, Aaron M. Elliott · 2014 · PLoS ONE
61. The Spectrum of Genetic Mutations in Breast Cancer
    Asfandyar Sheikh, Syed Ather Hussain, Quratulain Ghori, Nida Naeem, Abul Fazil, Smith Giri, Brijesh Sathian, Prajeena Mainali, Dalal M. Al Tamimi · 2015 · Asian Pacific Journal of Cancer Prevention
62. Routine TP53 testing for breast cancer under age 30: ready for prime time?
    Jeanna Marie McCuaig, Susan Randall Armel, Ana Novokmet, Ophira Ginsburg, Rochelle Demsky, Steven Alexander Narod, David M. Malkin · 2012 · Familial Cancer
63. Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?
    Byrnes, Graham B, Southey, Melissa C, Hopper, John L · 2008 · Breast Cancer Research
64. The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium
    Setareh Moghadasi, Huong Meeks, Maaike P.G. Vreeswijk, Linda A.M. Janssen, Åke Borg, Hans Ehrencrona, Ylva Paulsson-Karlsson, Barbara Wappenschmidt, Christoph Engel, Andrea Gehrig et al. · 2017 · Journal of Medical Genetics
65. Role of genetic polymorphisms and ovarian cancer susceptibility
    Peter Andreas Fasching, Simon A. Gayther, Leigh Pearce, Joellen M. Schildkraut, Ellen L. Goode, Falk Clemens Thiel, Georgia Chenevix‐Trench, Jenny C. Chang-Claude, Shan Wang‐Gohrke, Susan J. Ramus et al. · 2009 · Molecular Oncology
66. Risk Prediction Models For Familial Breast Cancer
    Antonis C. Antoniou, Douglas F. Easton · 2006 · Future Oncology
67. Correlation between family history and characteristics of breast cancer
    Lei Liu, Xiaomeng Hao, Zian Song, Xiangcheng Zhi, Sheng Zhang, Jin Zhang · 2021 · Scientific Reports
68. Hereditary Cancer Syndromes and Risk Assessment
    2019 · Obstetrics and Gynecology
69. Cost‐effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers
    Jessica E. Cott Chubiz, Janie M. Lee, Michael E. Gilmore, Chung Yin Kong, Kathryn P. Lowry, Elkan F. Halpern, Pamela M. McMahon, Paula D, Ryan, G. Scott Gazelle · 2012 · Cancer
70. Women's Decision Making about Risk‐Reducing Strategies in the Context of Hereditary Breast and Ovarian Cancer: A Systematic Review
    A. Fuchsia Howard, Lynda G. Balneaves, Joan L. Bottorff · 2009 · Journal of Genetic Counseling
71. Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach
    Goli Samimi, Marcus Q. Bernardini, Lawrence C. Brody, Charlisse Caga-Anan, Ian Campbell, Georgia Chenevix‐Trench, Fergus J. Couch, Michael C. Dean, Joanne A. de Hullu, Susan M. Domchek et al. · 2017 · Journal of Clinical Oncology
72. BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing
    Andrea Mafficini, Michele Simbolo, Alice Parisi, Borislav Chavdarov Rusev, Claudio Luchini, Ivana Cataldo, Elena Piazzola, Nicola Sperandio, Giona Turri, Massimo Piergiuseppe Franchi et al. · 2016 · Oncotarget
73. Genomics Education in the Era of Personal Genomics: Academic, Professional, and Public Considerations
    Kiara V. Whitley, Josie A. Tueller, K. Scott Weber · 2020 · International Journal of Molecular Sciences
74. Male Breast Cancer: An Updated Review of Epidemiology, Clinicopathology, and Treatment
    Guoliang Zheng, José Pablo Leone · 2022 · Journal of Oncology
75. Risk Prediction of Complex Diseases from Family History and Known Susceptibility Loci, with Applications for Cancer Screening
    Hon‐Cheong So, Johnny S. H. Kwan, Stacey Shawn Cherny, Pak Chung Sham · 2011 · The American Journal of Human Genetics
76. Risk factors for a serous cancer precursor (“p53 signature”) in women with inherited BRCA mutations
    Aasia Saleemuddin, Ann Katherine Folkins, Leslie A. Garrett, Judy Ellen Garber, Michael George Muto, Christopher P. Crum, Shelley S. Tworoger · 2008 · Gynecologic Oncology
77. Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2and mutation-negative breast cancer families
    Hannaleena Eerola, Päivi Heikkilä, Anitta Tamminen, Kristiina Aittomäki, CARL P. BLOMQVIST, Heli A. Nevanlinna · 2005 · Breast Cancer Research
78. The inherited genetics of ovarian and endometrial cancer
    Simon A. Gayther, Paul D.P. Pharoah · 2010 · Current Opinion in Genetics & Development
79. Contribution ofBRCA1andBRCA2mutations to inherited ovarian cancer
    Susan J. Ramus, Patricia A. Harrington, Carole Pye, Richard A. DiCioccio, Mark J. Cox, Kim Garlinghouse-Jones, Ingrid A. Oakley-Girvan, Ian J. Jacobs, Richard M. Hardy, Alice S. Whittemore et al. · 2007 · Human Mutation
80. Diagnosis of Early Stage Ovarian Cancer by1H NMR Metabonomics of Serum Explored by Use of a Microflow NMR Probe
    Erwin Garcia, Chris Andrews, Jia Hua, Hyung Lae Kim, Dinesh K. Sukumaran, Thomas Szyperski, Kunle O. Odunsi · 2011 · Journal of Proteome Research
81. Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers
    Kelly A. Metcalfe, Henry T. Lynch, Parviz Ghadirian, Nadine Tung, Charmaine Kim‐Sing, Olufunmilayo Ibironke Olopade, Susan M. Domchek, Andrea F. Eisen, William David Foulkes, Barry P. Rosen et al. · 2011 · Breast Cancer Research and Treatment
82. The Trajectory of Psychological Impact in BRCA1/2 Genetic Testing: Does Time Heal?
    Tammy M. Beran, Annette L. Stanton, Lorna C. Kwan, Joyce L. Seldon, Julienne E. Bower, Andrea Vodermaier, Patricia A. Ganz · 2008 · Annals of Behavioral Medicine
83. Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer
    Erin Frances Cobain, Kara J. Milliron, Sofia Diana Merajver · 2016 · Seminars in Oncology
84. Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families
    Jun Li, Huong Meeks, Bing Feng, Sue C. Healey, Heather Thorne, Igor V. Makunin, Jonathan J. Ellis, kConFab Investigators,, Ian Campbell, Melissa C. Southey et al. · 2015 · Journal of Medical Genetics
85. BRCA-associated Cancers: Role of Imaging in Screening, Diagnosis, and Management
    Michelle V. Lee, Venkata Subbiah Katabathina, Michyla Bowerson, Marina I. Mityul, Anup S. Shetty, Khaled M. Elsayes, Aparna Balachandran, Priya Bhosale, Ann E. McCullough, Christine O. Menias · 2017 · Radiographics
86. Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer
    J. Simard, M. Dumont, A. Moisan, V. Gaborieau, H. Malouin, F. Durocher, J. Chiquette, M. Plante, D. Avard, P. Bessette et al. · 2006 · Journal of Medical Genetics
87. Magnetic Resonance Imaging Improves Breast Screening Sensitivity in BRCA Mutation Carriers Age ≥ 50 Years: Evidence From an Individual Patient Data Meta-Analysis
    Xuan-Anh Phi, Nehmat Houssami, Inge-Marie Obdeijn, Ellen Warner, Francesco Sardanelli, Martin O. Leach, Christopher C. Riedl, Isabelle Trop, Madeleine M. A. Tilanus‐Linthorst, Rodica Mandel et al. · 2014 · Journal of Clinical Oncology
88. Reproductive decision-making in young female carriers of a BRCA mutation
    Louise S. Donnelly, Maggie Watson, Clare Moynihan, Elizabeth Kathryn Bancroft, D. Gareth Evans, Rosalind A. Eeles, Stuart A. Lavery, Elizabeth Ormondroyd · 2013 · Human Reproduction
89. Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers
    Roger Laughlin Milne, Antonis C. Antoniou · 2016 · Endocrine Related Cancer
90. Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy
    Kelly K. Hunt, David Euhus, Judy Caroline Boughey, Anees B. Chagpar, Sheldon Marc Feldman, Nora M Hansen, Swati Kulkarni, David R. McCready, Eleftherios P. Mamounas, Lee Gravatt Wilke et al. · 2016 · Annals of Surgical Oncology
91. Molecular Oncology of Breast Cancer
    Himanshu N. Joshi, Michael F. Press · 2017 · Elsevier eBooks
92. Tumor-derived exosomes in ovarian cancer - liquid biopsies for early detection and real-time monitoring of cancer progression
    Shayna Sharma, Felipe Andrés Zuñiga, Gregory Edward Rice, Lewis C Perrin, John David Hooper, Carlos Salomón · 2017 · Oncotarget
93. Prophylactic mastectomy for the prevention of breast cancer: Review of the literature
    Rawan K. Alaofi, Mohammed O. Nassif, Marwan Al‐Hajeili · 2018 · Avicenna Journal of Medicine
94. BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia
    Alexandra Ortiz Rodríguez, Marcia Llacuachaqui, Gonzalo Guevara Pardo, Robert Royer, Garrett P. Larson, Jeffrey N. Weitzel, Steven Alexander Narod · 2011 · Gynecologic Oncology
95. DNA methylation profiles in ovarian cancer: Implication in diagnosis and therapy (Review)
    Ourania Koukoura, Demetrios A. Spandidos, Alexandros I. Daponte, Stavros Sifakis · 2014 · Molecular Medicine Reports
96. Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: A WECARE Study Report
    Jonine L. Bernstein, Duncan C. Thomas, Roy E. Shore, Mark E. Robson, John D. Boice, Marilyn A. Stovall, Michael Andersson, Leslie Bernstein, Kathleen E. Malone, Anne S. Reiner et al. · 2013 · European Journal of Cancer
97. Germline Mutation in ATR in Autosomal- Dominant Oropharyngeal Cancer Syndrome
    Akio Tanaka, Sarah Weinel, Nikoletta Nagy, Mark O’Driscoll, Joey E. Lai‐Cheong, Carol L. Kulp‐Shorten, Alfred L. Knable, Gillian Carpenter, Sheila A. Fisher, Makiko Hiragun et al. · 2012 · The American Journal of Human Genetics
98. Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Xianshu Wang, V. Shane Pankratz, Zachary Fredericksen, Robert F. Tarrell, Mary Karaus, Lesley McGuffog, Paul D. P. Pharaoh, Bruce A.J. Ponder, Alison M. Dunning, Susan Peock et al. · 2010 · Human Molecular Genetics
99. Missed therapeutic and prevention opportunities in women with BRCA‐mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature
    Paul J Hoskins, Walter Henri Gotlieb · 2017 · CA A Cancer Journal for Clinicians
100. A mini review of bisphenol A (BPA) effects on cancer-related cellular signaling pathways
     Samira Nomiri, Reyhane Hoshyar, Concetta Ambrosino, Charles R. Tyler, Borhan Mansouri · 2019 · Environmental Science and Pollution Research